Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Bortezomib, response and retreatment in 1st, 2nd, 3rd and 4th line of treatment in patients with multiple myeloma
Show others and affiliations
2012 (English)In: Haematologica, ISSN 0390-6078, E-ISSN 1592-8721, Vol. 97, no supplement 1, 610-610 p.Article in journal (Refereed) Published
Place, publisher, year, edition, pages
2012. Vol. 97, no supplement 1, 610-610 p.
National Category
Medical and Health Sciences
Identifiers
URN: urn:nbn:se:kth:diva-141428OAI: oai:DiVA.org:kth-141428DiVA: diva2:696775
Conference
17th congress of European Hematology Association, EHA, June 14-17 2012,Amsterdam,The Netherlands
Note

Qc 20140925

Available from: 2014-02-15 Created: 2014-02-15 Last updated: 2017-12-06Bibliographically approved

Open Access in DiVA

No full text

Authority records BETA

Näsman, P

Search in DiVA

By author/editor
Näsman, P
By organisation
Centre for Transport Studies, CTSTransport and Location Analysis
In the same journal
Haematologica
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric score

urn-nbn
Total: 59 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf